Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Altimmune Inc., 2 years.
Altimmune Inc.
Director
Oncolytics Biotech Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 12, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +30,000 | $0.84 | $25,200 |
| Jan 8, 2026 | Altimmune Inc. | Open-market purchase | +5,000 | $4.08 | $20,400 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.